ChargePoint Technology acquires PuroVaso for greater range of powder and liquid transfer solutions
ChargePoint Technology has acquired PuroVaso, leader in the design, development, and manufacture of single-use containers, handling equipment, and accessories for pharma, biopharma, and life sciences.
Powder and liquid transfer specialist ChargePoint Technology group have announced their acquisition of PuroVaso, a pharmaceutical product wholesaler of single-use containers, handling equipment, and accessories for the pharma, biopharma, and life sciences markets.
With the addition of PuroVaso to ChargePoint Technology’s portfolio of containment and sterile transfer technology, pharmaceutical manufacturers will have a greater range of powder and liquid transfer storage and handling products to choose from in order to satisfy application specific problems. ChargePoint Technology is a solution provider for powder containment and aseptic transfer valves, providing its customers with operator safety and sterility assurance in the pharmaceutical, biotech, chemical, and process industries.
CEO of ChargePoint Technology Chris Eccles stated: “PuroVaso has vast technical expertise in pharmaceutical processing, transfer, handling, and storage with a broad portfolio of products that customers rely on for critical process applications… With its extensive process knowledge, application engineered solutions, and relentless customer focus, PuroVaso offers leading solutions to highly regulated pharma and biopharma landscapes along with several other process critical markets. We are very excited to have PuroVaso join the ChargePoint portfolio of solutions.”
Additionally, Steve Boswell, Co-Founder and Director of PuroVaso, commented: “We are very proud to have developed a handling solution that provides an altogether improved and sustainable approach to handling powders. Now is the time to allow the PuroVaso product line to reach its true potential with Chargepoint.
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Women in Pharma: CPHI India – India’s Pharmaceutical Industry and Gender Inclusion Challenges
India’s pharmaceutical industry has emerged as a significant player in the global market, valued at USD 50 billion in FY 2023-2024, according to Frost & Sullivan’s analysis. This sector encompasses a diverse portfolio, including drugs, vacc... -
News Biogen acquires Apellis Pharmaceuticals to boost immunology and rare disease profile
Biogen Inc. has announced its acquisition of Apellis Pharmaceuticals, Inc., a move that is set to significantly enhance its growth portfolio in immunology and rare diseases. The agreement, valued at approximately US$5.6 billion, will see Biogen purchas... -
News Gilead Sciences acquires Ouro Medicines for over US$2 billion
Gilead Sciences confirms a deal to take over Ouro Medicines, adding to a portfolio of therapies for autoimmune diseases.
-
News Women in Pharma: Advancing Women's Health
Discover the latest innovations in technologies and therapeutics that are revolutionising women's health in our latest CPHI Online Women in Pharma infographic.
-
News CPHI Pharma Awards 2026: Recognising Excellence in an Evolving Industry
Submissions now open — deadline May 16
-
News Dr Reddy's to launch generic semaglutide in India
Dr Reddy’s Laboratories, one of India’s leading pharmaceutical companies, is preparing to launch a generic version of semaglutide, branded as Obeda, in March. Obeda is expected to provide a more affordable alternative to Ozempic a... -
News Frontier Biotech and GSK Forge RNA Therapy Partnership
Frontier Biotechnologies and GSK have entered a global licensing agreement to advance small interfering RNA (siRNA) therapeutics. This collaboration grants GSK exclusive rights to develop and commercialise two promising siRNA candidates, marking a mile...